HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Wunderink, R. G. Search for Related Content PubMed PubMed Citation Articles by Wunderink, R. G.

Nosocomial Pneumonia, Including Ventilator-associatedPneumonia

Pulmonary and Critical Care Division, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois

Correspondence and requests for reprints should be addressed to Richard G. Wunderink, Pulmonary and Critical Care Division, Department of Medicine, Northwestern University Feinberg School of Medicine, 676 North St Clair, Suite 14-044, Chicago, IL 60611. E-mail: r-wunderink{at}northwestern.edu

ABSTRACT

Patients with nosocomial pneumonia have evidence of immunosuppression. The most obvious defect in immunity is the loss of mechanical barriers with an endotracheal tube. Only a third of colonized patients on ventilators develop pneumonia, however, suggesting that altered immunity is more extensive. This subgroup of patients tends to get multiple synchronous and sequential infections. The exact mechanisms of this compromise of immunity remain to be fully elucidated. Both a temporary immunocompromised and a specifically predisposed subpopulation, however, can explain the clinical pattern. A temporary immunoparalysis clearly occurs and is associated with increased risk of infections. An underlying genetic predisposition may lead to a predisposed population. Genetic polymorphisms in pathogen recognition molecules increase the risk of nosocomial infections. Genetic variability in immune mediators increase severity of infections and mortality but have not been demonstrated as consistently to lead to infections. Adequate treatment of an initial infection is required for reversal of the temporary immunoparalysis, whereas specific immunomodulatory therapies can reverse the markers of immunoparalysis and may decrease the risk of infection.

Key Words: immunoparalysis • nosocomial infections • pneumonia • polymorphisms

This article has been cited by other articles:

				J. Pugin, I. Dunn-Siegrist, J. Dufour, P. Tissieres, P.-E. Charles, and R. Comte Cyclic Stretch of Human Lung Cells Induces an Acidification and Promotes Bacterial Growth Am. J. Respir. Cell Mol. Biol., March 1, 2008; 38(3): 362 - 370. [Abstract] [Full Text] [PDF]

				A. Klekner, K. Bagyi, L. Bognar, A. Gaspar, M. Andrasi, and J. Szabo Effectiveness of cephalosporins in the sputum of patients with nosocomial bronchopneumonia. J. Clin. Microbiol., September 1, 2006; 44(9): 3418 - 3421. [Abstract] [Full Text] [PDF]